THQ
Income statement / Annual
Last year (2025), abrdn Healthcare Opportunities Fund's total revenue was -$100.83 M,
a decrease of 152.77% from the previous year.
In 2025, abrdn Healthcare Opportunities Fund's net income was -$114.84 M.
See abrdn Healthcare Opportunities Fund,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
09/30/2025 |
09/30/2024 |
09/30/2023 |
09/30/2022 |
09/30/2021 |
09/30/2020 |
09/30/2019 |
09/30/2018 |
09/30/2017 |
09/30/2016 |
| Operating Revenue |
-$100.83 M |
$191.10 M |
$80.51 M |
$69.58 M |
$196.54 M |
$118.37 M |
-$40.14 M |
$97.71 M |
$102.78 M |
$54.59 M |
| Cost of Revenue |
$12.91 M
|
$0.00
|
$12.31 M
|
$13.17 M
|
$0.00
|
$0.00
|
$11.45 M
|
$11.76 M
|
$11.58 M
|
$11.65 M
|
| Gross Profit |
-$113.75 M
|
$191.10 M
|
$68.21 M
|
$56.40 M
|
$196.54 M
|
$118.37 M
|
-$51.58 M
|
$85.95 M
|
$91.20 M
|
$42.94 M
|
| Gross Profit Ratio |
1.13
|
1
|
0.85
|
0.81
|
1
|
1
|
1.29
|
0.88
|
0.89
|
0.79
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.27
|
$1.69
|
$1.62
|
| General & Administrative Expenses |
$1.08 M
|
$1.50 M
|
$1.31 M
|
$1.48 M
|
$1.28 M
|
$1.17 M
|
$1.18 M
|
$1.29 M
|
$1.39 M
|
$160.39 K
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$160.39 K
|
| Selling, General & Administrative Expenses |
$1.08 M
|
$1.50 M
|
$1.31 M
|
$1.48 M
|
$1.28 M
|
$1.17 M
|
$1.18 M
|
$1.29 M
|
$1.39 M
|
$1.62
|
| Other Expenses |
$13.98 K
|
$38.76 K
|
$586.94 K
|
$616.47 K
|
$610.99 K
|
$554.08 K
|
$541.90 K
|
$557.46 K
|
$548.75 K
|
$43.73 M
|
| Operating Expenses |
$1.10 M
|
$1.54 M
|
$1.90 M
|
$2.10 M
|
$1.89 M
|
$1.72 M
|
$1.72 M
|
$1.85 M
|
$1.94 M
|
-$48.73 M
|
| Cost And Expenses |
$14.01 M
|
$1.54 M
|
$14.63 M
|
$152.00 M
|
$1.89 M
|
$1.72 M
|
$1.72 M
|
$1.85 M
|
$1.94 M
|
$42.94 M
|
| Interest Income |
$7.19 M
|
$9.24 M
|
$7.13 M
|
$4.90 M
|
$4.56 M
|
$5.78 M
|
$5.70 M
|
$5.64 M
|
$5.82 M
|
$0.00
|
| Interest Expense |
$12.91 M
|
$14.97 M
|
$13.09 M
|
$3.83 M
|
$2.13 M
|
$4.65 M
|
$7.34 M
|
$5.96 M
|
$4.32 M
|
$3.09 M
|
| Depreciation & Amortization |
$0.00
|
$0.00
|
$52.36 M
|
$228.49 K
|
$236.56 K
|
$206.30 K
|
$171.86 K
|
$161.14 K
|
$52.52 K
|
$161.43 M
|
| EBITDA |
-$114.84 M |
$204.54 M |
$65.88 M |
-$82.20 M |
$194.89 M |
$0.00 |
-$41.86 M |
$101.82 M |
$105.16 M |
$88.58 M |
| EBITDA Ratio |
1.14
|
1.07
|
0.82
|
-1.18
|
0.99
|
0
|
1.04
|
1.04
|
1.02
|
1.62
|
| Operating Income Ratio |
1.14
|
1.07
|
0.17
|
-1.18
|
0.99
|
0.99
|
1.04
|
1.04
|
1.02
|
1.68
|
| Total Other Income/Expenses Net |
$0.00
|
-$14.97 M
|
$39.26 M
|
-$3.83 M
|
$0.00
|
$0.00
|
$0.00
|
$11.76 M
|
$11.58 M
|
-$3.09 M
|
| Income Before Tax |
-$114.84 M
|
$189.56 M
|
$52.79 M
|
-$86.25 M
|
$194.65 M
|
$116.64 M
|
-$41.86 M
|
$95.86 M
|
$100.84 M
|
$88.58 M
|
| Income Before Tax Ratio |
1.14
|
0.99
|
0.66
|
-1.24
|
0.99
|
0.99
|
1.04
|
0.98
|
0.98
|
1.62
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$161.14 K
|
-$52.52 K
|
$0.00
|
| Net Income |
-$114.84 M
|
$189.56 M
|
$52.79 M
|
-$86.25 M
|
$194.65 M
|
$116.64 M
|
-$41.86 M
|
$95.86 M
|
$100.84 M
|
$91.67 M
|
| Net Income Ratio |
1.14
|
0.99
|
0.66
|
-1.24
|
0.99
|
0.99
|
1.04
|
0.98
|
0.98
|
1.68
|
| EPS |
-2.78 |
4.58 |
1.28 |
-2.09 |
4.71 |
2.82 |
-1.01 |
2.28 |
2.32 |
2.11 |
| EPS Diluted |
-2.78 |
4.58 |
1.28 |
-2.09 |
4.71 |
2.82 |
-1.01 |
2.28 |
2.32 |
2.11 |
| Weighted Average Shares Out |
$41.38 M
|
$41.36 M
|
$41.24 M
|
$41.36 M
|
$41.33 M
|
$41.36 M
|
$41.46 M
|
$42.05 M
|
$43.47 M
|
$43.55 M
|
| Weighted Average Shares Out Diluted |
$41.38 M
|
$41.39 M
|
$41.24 M
|
$41.36 M
|
$41.33 M
|
$41.36 M
|
$41.46 M
|
$42.05 M
|
$43.47 M
|
$43.55 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
